Authors: Brandenburg, AH Neijens, HJ Osterhaus, ADME

Citation: Ah. Brandenburg et al., Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development, VACCINE, 19(20-22), 2001, pp. 2769-2782

Authors: Brandenburg, AH Kleinjan, A Land, BV Moll, HA Timmerman, HH de Swart, RL Neijens, HJ Fokkens, W Osterhaus, ADME

Citation: Ah. Brandenburg et al., Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity, J MED VIROL, 62(2), 2000, pp. 267-277

Authors: Brandenburg, AH van Beek, R Moll, HA Osterhaus, ADME Claas, ECJ

Citation: Ah. Brandenburg et al., G protein variation in respiratory syncytial virus group A does not correlate with clinical severity, J CLIN MICR, 38(10), 2000, pp. 3849-3852

Authors: Ang, CW Jacobs, BC Brandenburg, AH Laman, JD van der Meche, FGA Osterhaus, ADME van Doorn, PA

Citation: Cw. Ang et al., Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barre syndrome, NEUROLOGY, 54(7), 2000, pp. 1453-1458

Authors: Brandenburg, AH de Waal, L Timmerman, HH Hoogerhout, P de Swart, RL Osterhaus, ADME

Citation: Ah. Brandenburg et al., HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein, J VIROLOGY, 74(21), 2000, pp. 10240-10244